Posts

In his role as a medical writer, Willis will develop disease- and treatment-related content to help Peregrine’s pharmaceutical and biotechnology clients communicate the value of their treatments, diagnostics, and medical devices.

A Q&A with Wendy Carhart of Real Chemistry

FCB Health Europe announces two new leadership roles appointed to support the group’s ongoing growth following the formation of IPG Health last year.

Ashfield and Huntsworth unite their full suite of advisory, medical, marketing, communications and patient and stakeholder engagement services to create Inizio, a strategic partner to health and life science companies throughout the life cycle of their drug products.

Meltmedia, an award-winning provider of digital strategy, design, and development services to the life science industry, has been acquired by Evoke, a global brand, experience, and communications platform, purpose-built to make health more human.

FCB Health wins Healthcare Network of the Year, AREA 23 wins Healthcare Agency of the Year and notches Health Grand Prix for Good.

Erica Rivera is vice president, director of engagement strategy at AbelsonTaylor.

More than 90 percent of rare diseases have no FDA-approved treatment, and it can take seven to eight years just to get diagnosed. It’s a zero-sum game for marketers because we’re walking onto an empty field full of people desperate for someone to join their team. We have the opportunity to make a substantial impact in the small towns of rare disease.

Joanna Jacobs came on board as president of TBWA\WorldHealth a few months ago. Med Ad News recently caught up with her and CEO Robin Shapiro to talk about how Jacobs came to the agency, her plans for the next few months, and her commitment to diversity, equity, and inclusion (DE&I).

Peregrine Market Access, a full-service consulting, communications and commercialization partner for the life science industry, welcomes Ronald Deng, MS, PharmD, as a new addition to the content strategy department.